Import Restrictions on Synthetic Cannabinoids
The Drug Enforcement Administration has extended through July 10, 2021, an order temporarily including the following synthetic cannabinoids, including their optical, positional, and geometric isomers, salts, and salts of isomers, into schedule I of the Controlled Substances Act.
- naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (trivial names: NM2201; CBL2201)
- N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1Hindazole-3-carboxamide (trivial name: 5F-AB-PINACA)
- 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (trivial names: 4-CN-CUMYLBUTINACA; 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CNBINACA; SGT-78)
- methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (trivial names: MMB-CHMICA, AMB-CHMICA)
- 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name: 5F-CUMYL-P7AICA)
As a result, the DEA will continue to impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances under the CSA on the importation, exportation, manufacture, distribution, reverse distribution, possession, research and conduct of instructional activities, and chemical analysis of these substances.
At the same time, the DEA has issued a proposed rule that would permanently place the substances listed above into schedule I. Comments on this proposal are due no later than Aug. 12.